Fitness Trackers May Help Detect Potentially Dangerous Irregular Heartbeats
The wrist-worn devices may identify patients who would benefit from stroke prevention therapies.
Contact Information
Boston, MAPhone: 866-644-8910
Boston, MAPhone: 617-724-4500
Dr. Lubitz graduated from the University of Michigan Medical School. He trained in internal medicine and cardiovascular disease at the Mount Sinai Hospital in New York, where he also served as a Chief Medical Resident. Dr. Lubitz earned a Master of Public Health degree from the Harvard University School of Public Health. He completed his clinical electrophysiology training at the Massachusetts General Hospital.
His clinical interests are focused on the diagnosis and treatment of patients with cardiac arrhythmias. He performs catheter ablations for supraventricular tachycardias (SVTs), and implantation and follow-up of pacemakers, cardiac resynchronization therapy (CRT) devices, and implantable cardioverter defibrillators (ICDs).
Dr. Lubitz has clinical and research interests in caring for patients with heritable arrhythmias, including early onset atrial fibrillation, Brugada syndrome, long QT syndrome, short QT syndrome, unexplained ventricular tachycardia and fibrillation, arrhythmogenic right ventricular cardiomyopathy, and catecholaminergic polymorphic ventricular tachycardia.
Dr. Lubitz is currently accepting new patients.
Clinical Interests:
Treats:
Mass General Heart Center
55 Fruit St.
Boston, MA 02114
Phone: 866-644-8910
Mass General: Demoulas Center for Cardiac Arrhythmias
55 Fruit St.
Boston, MA 02114
Phone: 617-724-4500
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Lubitz' research focuses on clinical and genetic aspects of heritable cardiac arrhythmias. He is interested in studying the mechanisms of heritable arrhythmias and determining how genetic information can be used to guide care. Dr. Lubitz' research spans disciplines including epidemiology, risk prediction, population genetics, pharmacogenetics, and clinical trials to identify the role of using genetic information in clinical practice.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
The wrist-worn devices may identify patients who would benefit from stroke prevention therapies.
A clinical-economics research team provides important new evidence at a time of conflicting health system guidelines for AF screening globally.
Advanced consumer technology has produced small electrocardiogram devices that could be efficiently deployed in point-of-care screening for atrial fibrillation, though the proportion of cases detected among all patients 65 and older is small.
The advance may help clinicians protect patients’ heart health and prevent strokes.
The use of accelerometers enables researchers to provide the most objective evidence to date of the link between physical activity and atrial fibrillation.